DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment

 

 

Oncology Homepage

Varian ARIA, Eclipse and TrueBeam named Category Leaders in the 2018 Best in KLAS: Software and Services Report

Liquid biopsy can help predict outcomes in metastatic triple-negative breast cancer

Provision Healthcare treats first patients using ProNova SC360 proton therapy system

ACA lowered uninsured rate for cancer survivors, study found

Aetna will cover Augmenix's SpaceOAR Hydrogel procedure for men with prostate cancer

Survey shows marginal enrollment increase in radiography educational programs

University of Delaware researchers develop accurate model of how aggressive cancer cells move and spread

U.S. Preventive Services Task Force recommends against screening for ovarian cancer

Europe's first compact proton accelerator arrives in the Netherlands

Median Technologies announces results of deep learning study for enhanced prostate segmentation

North America radiotherapy devices market to reach over $3500 million by 2027

Press releases may be edited for formatting or style
NEW YORK, Sept. 7, 2017 /PRNewswire/ -- The global radiotherapy devices market is scattered across major geographies and seems to be witnessing relatively good growth across the key regional markets. An increasing expenditure on healthcare and sudden rise in the occurrence of cancer across the globe are the main drivers boosting revenue growth of the radiotherapy devices market at a global level. Further, governments of several countries are allocating a large share of their healthcare budget towards cancer research and bolstering this by implementing several awareness campaigns at a national level. These ancillary drivers are also fueling revenue growth of the global radiotherapy devices market to a significant extent.

The global market has several opportunities on offer for key players in the form of increasing government support for structured cancer R&D initiatives and a provision for up gradation of existing equipment and treatment capabilities based on technological advancements. The radiotherapy devices market is strictly governed by regulatory approvals that apply to the concerned regional markets such as the U.S. FDA Medical Device Regulatory Approval Process and the European Medicines Agency Regulatory Approval for Medical Devices; making it the most structured and well-scrutinised market for medical devices poised for good growth owing to all the factors listed above.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras



A US$ 4 Bn market, the global radiotherapy devices market will be distributed almost evenly across the top regional markets

In terms of market share, North America takes the cake in the global radiotherapy devices market, with an estimated 34% market share through the forecast period. Western Europe will occupy the second place, moving from an estimated 29% value share in 2017 to a little over 30% by the end of the forecast period. The Western Europe radiotherapy devices market will witness an increase of 93 basis points in its market share over the 10 year period while North America stands to lose 57 basis points in 2027 over 2017. High income nations especially in Northern-Western Europe are well-served with radiotherapy resources, which could probably explain the relatively high market share of Western Europe as compared to other regions. Countries in some of the developing economies still face shortages of both equipment and critical machinery capable of delivering high precision conformal treatments. Hence, the market share of regional markets such as Latin America and the Middle East & Africa are way low as compared to the share held by the developed economies such as North America and Western Europe.
  Pages: 1 - 2 >>

Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED